Application 005378

Type
NDA
Sponsor
RECORDATI RARE

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
002DESOXYNMETHAMPHETAMINE HYDROCHLORIDETABLET;ORAL5MGYesYes
003DESOXYNMETHAMPHETAMINE HYDROCHLORIDETABLET, EXTENDED RELEASE;ORAL10MGNoNo
004DESOXYNMETHAMPHETAMINE HYDROCHLORIDETABLET, EXTENDED RELEASE;ORAL5MGNoNo
005DESOXYNMETHAMPHETAMINE HYDROCHLORIDETABLET, EXTENDED RELEASE;ORAL15MGNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
55292-104Desoxynmethamphetamine hydrochlorideRecordati Rare Diseases Inc.NDACurrent
55292-104Desoxynmethamphetamine hydrochlorideRECORDATI RARE DISEASES, INC.NDACurrent
55292-104Desoxynmethamphetamine hydrochlorideRECORDATI RARE DISEASES, INC.NDACurrent
55292-104Desoxynmethamphetamine hydrochlorideRecordati Rare Diseases, Inc.NDACurrent
55292-104Desoxynmethamphetamine hydrochlorideRECORDATI RARE DISEASES, INC.NDACurrent
70868-820Desoxynmethamphetamine hydrochlorideKey TherapeuticsNDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
79741SUPPL 2024-09-26
79740SUPPL 2024-09-26
79732SUPPL 2024-09-26
75809SUPPL 2023-10-17
75757SUPPL 2023-10-16
70329SUPPL2022-03-01
70328SUPPL2022-03-01
70294SUPPL2022-02-28
58845SUPPL2019-05-23
58844SUPPL2019-05-23
58328SUPPL2019-04-15
48507SUPPL2017-05-24
48483SUPPL2017-05-22
46795SUPPL2017-01-11
46719SUPPL2017-01-06
63SUPPL2015-04-21
32931SUPPL2015-04-20
62SUPPL2013-12-09
32930SUPPL2013-12-04
32929SUPPL2013-08-27
15SUPPL2013-08-27
43993ORIG2011-12-20
10677SUPPL2007-05-16
61SUPPL2007-05-16
32928SUPPL2006-04-13
60SUPPL2006-04-13
32927SUPPL2003-04-03